Boundless Bio, Inc.

BOLD

Boundless Bio, Inc.

BOLD

Insider Sentiment (TTM):

Last Purchase:2026-06-29Last Sale:-Shares Purchased (TTM):64,762Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:8,376,328Shares Outstanding:22,407,000Institutional Ownership Pct.:37.38%

Earnings Market Reaction:

Filing Date:2026-05-08Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	17	18	15	15	15	27	40	31	25
Short Term Investments	75	90	103	112	123	126	127	148	80
Prepaid Expense And Other Assets Current	2	2	3	3	2	2	3	4	7
Assets Current	95	110	120	130	140	154	170	183	112
Property Plant And Equipment Net	3	3	3	4	4	4	4	4	2
Operating Lease Right Of Use Asset	43	44	44	45	46	47	0	1	1
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1	1
Other Assets	0	0	0	0	0	0	0	0	1
Assets	141	157	169	179	191	206	175	188	117
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	6	7	7	6	5	5	7	6	8
Employee Related Liabilities Current	1	3	2	1	1	3	3	2	1
Operating Lease Liability Current	3	3	3	2	0	-	0	1	2
Liabilities Current	10	13	12	9	6	8	10	9	11
Operating Lease Liability Noncurrent	45	46	47	48	48	48	-	-	-
Liabilities	55	58	59	57	55	56	-	-	-
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	0	0	0	248
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	360	358	357	356	354	352	350	348	10
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	0	-0	0	0	0	-0	-0
Retained Earnings Accumulated Deficit	-273	-260	-247	-233	-217	-201	-185	-169	-152
Stockholders Equity	86	99	110	123	137	151	165	179	-141
Liabilities And Stockholders Equity	141	157	169	179	191	206	175	188	117
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	0	0	0	0
Temporary Equity Liquidation Preference	-	-	-	-	-	-	-	-	252
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	70	70	70	70	70	70	70	70	70
Temporary Equity Shares Authorized	-	-	-	-	-	0	0	0	287
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	-
Temporary Equity Shares Issued	-	-	-	-	-	0	0	0	287
Temporary Equity Shares Outstanding	-	-	-	-	-	0	0	0	287
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	700	700	700	700	700	700	700	700	700
Common Stock Shares Issued	22	22	22	22	22	22	22	22	23
Shares Outstanding	22	22	22	22	22	22	22	22	20

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	0.69%	77.78%	-	-	-	-	-	-	-	-	-	-
2025	-23.61%	-29.86%	-12.15%	-5.08%	-3.39%	23.73%	-7.14%	-4.76%	0.00%	-5.26%	37.72%	27.19%
2024	1.05%	-56.41%	-66.60%	8.68%	10.42%	3.47%	-17.77%	-23.19%	-27.41%	-5.96%	9.27%	-30.46%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Liquidity Ratios
Current Ratio	9.87	8.74	10.14	14.08	22.15	18.98	17.03	20.45	10.54
Quick Ratio	9.69	8.58	9.93	13.80	21.81	18.70	16.70	20.02	9.85
Working Capital	85.03M	97.07M	108.31M	120.48M	134.03M	146.26M	160.44M	174.18M	101.52M
Leverage & Debt
Debt to Equity	0.63	0.59	0.53	0.46	0.40	0.37	0.06	0.05	-0.08
Debt Ratio	0.39	0.37	0.35	0.32	0.29	0.27	0.06	0.05	0.09
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Per Share Metrics
Diluted EPS TTM	-2.50	-2.60	-2.76	-2.88	-2.95	-3.85	-	-	-
Free Cash Flow Per Share TTM	-2.12	-2.11	-2.35	-2.52	-2.79	-3.73	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Growth Metrics
Net Income Growth (1Y)	-14.76%	-10.96%	-	-	-	-	-	-	-
EPS Growth (1Y)	-15.17%	-32.37%	-	-	-	-	-	-	-
Valuation Metrics
P/E TTM	-0.44	-0.46	-0.45	-0.35	-0.51	-0.75	-	-	-
P/B TTM	0.29	0.27	0.25	0.18	0.25	0.33	0.47	0.48	-2.03
Market Cap	24.65M	26.83M	27.53M	22.58M	33.67M	49.25M	77.22M	85.23M	286.82M
Enterprise Value	6.60M	8.40M	11.99M	7.88M	18.00M	22.11M	36.45M	53.31M	261.12M
Calculated Values
Free Cash Flow TTM	-47.60M	-47.21M	-52.71M	-56.24M	-62.11M	-63.38M	-	-	-
Net Debt	-18.04M	-18.43M	-15.54M	-14.70M	-15.68M	-27.15M	-40.77M	-31.92M	-25.70M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-29Purchase

Owner: Tang, Kevin, Tang Capital…

Title: -

Shares: 64,762

Price/Share: $2.48

Value: $160,609.76

Shares Owned: 2,533,845

Relationship: TenPercentOwner

Ownership: Indirect

2024-04-02Purchase

Owner: Burow, Kristina

Title: -

Shares: 200,000

Price/Share: $16.00

Value: $3,200,000.00

Shares Owned: 1,181,766

Relationship: Director,TenPercentOwner

Ownership: Indirect

2024-04-02Purchase

Owner: Kolchinsky, Peter, Shah R…

Title: -

Shares: 312,500

Price/Share: $16.00

Value: $5,000,000.00

Shares Owned: 1,884,787

Relationship: TenPercentOwner

Ownership: Indirect

2024-04-02Purchase

Owner: Arch, Venture Partners Ix…

Title: -

Shares: 200,000

Price/Share: $16.00

Value: $3,200,000.00

Shares Owned: 1,181,766

Relationship: TenPercentOwner

Ownership: Indirect

2024-04-02Purchase

Owner: Gillis, Steven, Nelsen Ro…

Title: -

Shares: 200,000

Price/Share: $16.00

Value: $3,200,000.00

Shares Owned: 1,181,766

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-29	Tang, Kevin, Tang Capital…	TenPercentOwner	-	Indirect	Purchase	64,762	2.48	$160,609.76	2,533,845	4
2024-04-02	Burow, Kristina	Director,TenPercentOwner	-	Indirect	Purchase	200,000	16.00	$3,200,000.00	1,181,766	4
2024-04-02	Kolchinsky, Peter, Shah R…	TenPercentOwner	-	Indirect	Purchase	312,500	16.00	$5,000,000.00	1,884,787	4
2024-04-02	Arch, Venture Partners Ix…	TenPercentOwner	-	Indirect	Purchase	200,000	16.00	$3,200,000.00	1,181,766	4
2024-04-02	Gillis, Steven, Nelsen Ro…	TenPercentOwner	-	Indirect	Purchase	200,000	16.00	$3,200,000.00	1,181,766	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

37.38%

Inst. Shares: 8,376,328

Shares Outstanding: 22,407,000

2025-12-31

38.94%

Inst. Shares: 8,705,924

Shares Outstanding: 22,360,000

2025-09-30

42.92%

Inst. Shares: 9,607,585

Shares Outstanding: 22,386,000

2025-06-30

43.59%

Inst. Shares: 9,744,149

Shares Outstanding: 22,356,000

2025-03-31

58.07%

Inst. Shares: 12,950,088

Shares Outstanding: 22,300,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	8,376,328	22,407,000	37.38%
2025-12-31	8,705,924	22,360,000	38.94%
2025-09-30	9,607,585	22,386,000	42.92%
2025-06-30	9,744,149	22,356,000	43.59%
2025-03-31	12,950,088	22,300,000	58.07%
2024-12-31	12,881,202	16,984,000	75.84%
2024-09-30	13,070,135	22,254,000	58.73%
2024-06-30	13,469,298	22,023,000	61.16%
2024-03-31	14,362,134	20,128,000	71.35%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Boundless Bio, Inc. (BOLD) — SEC Financial Statements & Analysis

Boundless Bio, Inc. (BOLD) is a pharmaceutical preparations company, incorporated in DE. Boundless Bio, Inc. trades on Nasdaq as: BOLD. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Boundless Bio, Inc. reported a Debt-to-Equity ratio of 0.63x, a Price-to-Book (P/B) ratio of 0.29 (TTM), at a market cap of $24.65M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.63x
P/B TTM: 0.29
Market Cap: $24.65M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Boundless Bio, Inc. in?

Boundless Bio, Inc. (BOLD) operates in the Pharmaceutical Preparations industry.

What is BOLD's market cap?

Boundless Bio, Inc. (BOLD) has a market capitalization of $24.65M as of 2026-03-31.

What exchange does BOLD trade on?

Boundless Bio, Inc. (BOLD) trades on the Nasdaq.

Where is Boundless Bio, Inc. incorporated?

Boundless Bio, Inc. is incorporated in DE.

Boundless Bio, Inc. (BOLD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.